TIA NWANGUMA: Open Payments
NPI 1598542870 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $150 |
| Novo Nordisk Inc | 1 | $121 |
| Astellas Pharma Global Development | 1 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: Repatha, Wegovy, Veozah, REXULTI.
Industry payments across NC — which companies pay providers there.
